March 11, 2026 - 10:16

In the wake of swirling trade speculation that linked star defensive end Maxx Crosby to the Baltimore Ravens, the player's representation has moved to directly address and dismiss concerns regarding his physical condition. The rumors, which gained traction during the recent NFL draft, suggested potential off-season surgeries might be a factor in any discussions.
Crosby's agent has now firmly shut down that narrative, emphasizing the defensive star's health and commitment to the Las Vegas Raiders. He clarified that Crosby has not required any surgical procedures this offseason and is, in fact, in excellent shape as he prepares for the upcoming campaign.
The statement serves to quell fan anxiety and redirect focus toward Crosby's on-field leadership. The 2023 season saw Crosby deliver another dominant, All-Pro caliber performance, solidifying his status as the cornerstone of the Raiders' defense. This public reassurance from his camp underscores Crosby's continued dedication to the franchise that drafted him, aiming to put the brief but noisy trade saga firmly in the rearview mirror as the team looks ahead to the new season.
July 25, 2026 - 03:23
Cyclospora Outbreak Grows, Affecting Nine StatesFederal investigators continue to search for the sources amid the largest number of reported cyclosporiasis cases in US history. Health officials have confirmed that the outbreak has now spread to...
July 24, 2026 - 09:13
The Benefits of Exercise for Mental HealthIt is common knowledge that regular exercise strengthens the heart, builds muscle, and helps manage weight. But according to Dr. John Ratey, a clinical associate professor of psychiatry at Harvard...
July 23, 2026 - 21:07
U.S. health officials investigate new outbreak of parasite cyclosporaFederal health authorities are investigating a new outbreak of the intestinal parasite cyclospora, though they have not yet pinpointed the specific food source responsible for the illnesses. The...
July 23, 2026 - 03:37
US regulators to weigh controversial peptides backed by RFK JrU.S. regulators are preparing to evaluate a class of controversial peptides that have gained a passionate following, partly due to endorsements from Robert F. Kennedy Jr. The compounds, often sold...